Autoimmune autonomic ganglionopathy
| Autoimmune autonomic ganglionopathy | |
|---|---|
| Synonyms | AAG |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Severe orthostatic hypotension, anhidrosis, constipation, urinary retention, dry mouth, dry eyes |
| Complications | N/A |
| Onset | Typically acute or subacute |
| Duration | Can be chronic |
| Types | N/A |
| Causes | Autoimmune disease targeting nicotinic acetylcholine receptors in autonomic ganglia |
| Risks | Genetic predisposition, viral infection |
| Diagnosis | Clinical evaluation, serological testing for ganglionic acetylcholine receptor antibodies |
| Differential diagnosis | Multiple system atrophy, pure autonomic failure, Guillain-Barré syndrome |
| Prevention | N/A |
| Treatment | Immunotherapy (e.g., IVIG, plasmapheresis, corticosteroids), symptomatic treatment |
| Medication | N/A |
| Prognosis | Variable; some patients improve with treatment, others may have persistent symptoms |
| Frequency | Rare |
| Deaths | N/A |
Autoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by the immune system mistakenly attacking the autonomic ganglia, which are clusters of nerve cells that regulate the autonomic nervous system (ANS). The ANS controls involuntary bodily functions such as heart rate, blood pressure, digestion, and temperature regulation.
Pathophysiology[edit]
The pathophysiology of AAG involves the production of autoantibodies that target the nicotinic acetylcholine receptors (nAChRs) located in the autonomic ganglia. These receptors are crucial for the transmission of nerve signals within the ANS. The binding of autoantibodies to these receptors disrupts normal autonomic function, leading to a wide range of symptoms.
Symptoms[edit]
The symptoms of AAG can vary widely depending on the extent and location of autonomic dysfunction. Common symptoms include:
- Severe orthostatic hypotension, leading to dizziness or fainting upon standing
- Gastrointestinal dysmotility, resulting in nausea, vomiting, constipation, or diarrhea
- Anhidrosis or hyperhidrosis, affecting the body's ability to regulate temperature
- Urinary retention or incontinence
- Pupillary abnormalities, such as fixed or dilated pupils
- Dry mouth and dry eyes
Diagnosis[edit]
Diagnosing AAG involves a combination of clinical evaluation, laboratory tests, and autonomic function tests. Key diagnostic steps include:
- Clinical evaluation: A thorough history and physical examination to assess symptoms and rule out other conditions.
- Serological tests: Detection of ganglionic acetylcholine receptor antibodies in the blood, which are present in many cases of AAG.
- Autonomic function tests: These may include tilt table testing, quantitative sudomotor axon reflex test (QSART), and heart rate variability analysis to assess autonomic function.
Treatment[edit]
Treatment of AAG focuses on managing symptoms and modulating the immune response. Options include:
- Immunotherapy: Such as intravenous immunoglobulin (IVIG), plasmapheresis, or immunosuppressive drugs like corticosteroids, azathioprine, or rituximab.
- Symptomatic treatment: Medications to manage specific symptoms, such as fludrocortisone or midodrine for orthostatic hypotension, and prokinetic agents for gastrointestinal symptoms.
Prognosis[edit]
The prognosis of AAG varies. Some patients may experience significant improvement with treatment, while others may have persistent symptoms. Early diagnosis and treatment are crucial for better outcomes.
